|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.2 HKD | 0.00% |
|
+0.84% | -12.41% |
Fusen Pharmaceutical Company Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 565.61 million compared to CNY 491.76 million a year ago. Net loss was CNY 36.28 million compared to CNY 34.61 million a year ago.
Basic loss per share from continuing operations was CNY 0.05 compared to CNY 0.05 a year ago. Diluted loss per share from continuing operations was CNY 0.05 compared to CNY 0.05 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.41% | 11Cr | |
| +16.31% | 4.23TCr | |
| +16.32% | 2.13TCr | |
| +19.33% | 1.53TCr | |
| +18.71% | 1.44TCr | |
| +52.78% | 1.28TCr | |
| -0.05% | 678.76Cr | |
| -12.24% | 658.31Cr | |
| -8.87% | 572.55Cr | |
| +11.64% | 550.82Cr |
FUSEN PHARMACEUTICAL COMPANY LIMITED 
